Role of Cytokines and Chemokines in Angiogenesis in a Tumor Context
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of Cytokines and Chemokines in Angiogenesis in a Tumor Context
Authors
Keywords
-
Journal
Cancers
Volume 14, Issue 10, Pages 2446
Publisher
MDPI AG
Online
2022-05-17
DOI
10.3390/cancers14102446
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IL-12 Family Cytokines in Cancer and Immunotherapy
- (2021) Bhalchandra Mirlekar et al. Cancers
- Inhibition of FGF‐FGFR and VEGF‐VEGFR signalling in cancer treatment
- (2021) Guihong Liu et al. CELL PROLIFERATION
- Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study
- (2021) Jennifer Mooi et al. CLINICAL CANCER RESEARCH
- Vascular Endothelial Growth Factor, a Key Modulator of the Anti-Tumor Immune Response
- (2021) Mannon Geindreau et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Regulation of redox signaling in HIF‐1‐dependent tumor angiogenesis
- (2021) Valeria Manuelli et al. FEBS Journal
- Historical overview of the interleukin-6 family cytokine
- (2020) Sujin Kang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- EGFR/Ras-induced CCL20 production modulates the tumour microenvironment
- (2020) Andreas Hippe et al. BRITISH JOURNAL OF CANCER
- Interleukin-35 promotes progression of prostate cancer and inhibits anti-tumour immunity
- (2020) Jialin Zhu et al. Cancer Cell International
- CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands
- (2020) Jan Korbecki et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- TGF-β suppresses type 2 immunity to cancer
- (2020) Ming Liu et al. NATURE
- Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance
- (2020) Melanie A. Krook et al. BRITISH JOURNAL OF CANCER
- CXCL5 induces tumor angiogenesis via enhancing the expression of FOXD1 mediated by the AKT/NF-κB pathway in colorectal cancer
- (2019) Chun Chen et al. Cell Death & Disease
- The γc Family of Cytokines: Basic Biology to Therapeutic Ramifications
- (2019) Warren J. Leonard et al. IMMUNITY
- Shared and Distinct Functions of Type I and Type III Interferons
- (2019) Helen M. Lazear et al. IMMUNITY
- FOLFOX alone or combined with rilotumumab or panitumumab as first-line treatment for patients with advanced gastroesophageal adenocarcinoma (PRODIGE 17-ACCORD 20-MEGA): a randomised, open-label, three-arm phase II trial
- (2019) David Malka et al. EUROPEAN JOURNAL OF CANCER
- Increased Antiangiogenic Effect by Blocking CCL2-dependent Macrophages in a Rodent Glioblastoma Model: Correlation Study with Dynamic Susceptibility Contrast Perfusion MRI
- (2019) Hye Rim Cho et al. Scientific Reports
- Placental growth factor regulates the generation of TH17 cells to link angiogenesis with autoimmunity
- (2019) Seung-Ah Yoo et al. NATURE IMMUNOLOGY
- The McCAVE Trial: Vanucizumab plus mFOLFOX‐6 Versus Bevacizumab plus mFOLFOX‐6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC)
- (2019) Johanna C. Bendell et al. ONCOLOGIST
- First-in-Human Phase I Study of Aprutumab Ixadotin, a Fibroblast Growth Factor Receptor 2 Antibody–Drug Conjugate (BAY 1187982) in Patients with Advanced Cancer
- (2019) Sung-Bae Kim et al. Targeted Oncology
- Interleukin-9 promotes tumorigenesis through augmenting angiogenesis in non-small cell lung cancer
- (2019) Jun He et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- A guide to chemokines and their receptors
- (2018) Catherine E. Hughes et al. FEBS Journal
- The PDGF/PDGFR pathway as a drug target
- (2018) Natalia Papadopoulos et al. MOLECULAR ASPECTS OF MEDICINE
- Phase II Study to Evaluate the Efficacy and Safety of Rilotumumab and Bevacizumab in Subjects with Recurrent Malignant Glioma
- (2018) Mary Lou Affronti et al. ONCOLOGIST
- Tryptase promotes breast cancer angiogenesis through PAR‑2 mediated endothelial progenitor cell activation
- (2018) Neng Qian et al. Oncology Letters
- Overview of the Mechanisms that May Contribute to the Non-Redundant Activities of Interferon-Inducible CXC Chemokine Receptor 3 Ligands
- (2018) Mieke Metzemaekers et al. Frontiers in Immunology
- Specific Antibody Fragment Ligand Traps Blocking FGF1 Activity
- (2018) Julia Chudzian et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CCL19 suppresses angiogenesis through promoting miR-206 and inhibiting Met/ERK/Elk-1/HIF-1α/VEGF-A pathway in colorectal cancer
- (2018) Zhuoqing Xu et al. Cell Death & Disease
- Interleukin-22 promotes tumor angiogenesis
- (2018) Nicholas J. Protopsaltis et al. ANGIOGENESIS
- Tryptase inhibitors: a patent review
- (2017) Wei-Wei Ni et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Therapeutic targeting of the angiopoietin–TIE pathway
- (2017) Pipsa Saharinen et al. NATURE REVIEWS DRUG DISCOVERY
- A Phase II Randomized Trial (GO27827) of First‐Line FOLFOX Plus Bevacizumab with or Without the MET Inhibitor Onartuzumab in Patients with Metastatic Colorectal Cancer
- (2017) Johanna C. Bendell et al. ONCOLOGIST
- Hepatocyte Growth Factor, a Key Tumor-Promoting Factor in the Tumor Microenvironment
- (2017) Benjamin Owusu et al. Cancers
- IL-15 regulates migration, invasion, angiogenesis and genes associated with lipid metabolism and inflammation in prostate cancer
- (2017) Krizia Rohena-Rivera et al. PLoS One
- Recent discovery of non-nucleobase thymidine phosphorylase inhibitors targeting cancer
- (2016) Hriday Bera et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- CCL11-induced eosinophils inhibit the formation of blood vessels and cause tumor necrosis
- (2016) Yanjiang Xing et al. GENES TO CELLS
- Inhibition of blood vessel formation in tumors by IL-18-polarized M1 macrophages
- (2016) Yanjiang Xing et al. GENES TO CELLS
- Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26
- (2016) David Kung-Chun Chiu et al. HEPATOLOGY
- Opposing actions of angiopoietin-2 on Tie2 signaling and FOXO1 activation
- (2016) Minah Kim et al. JOURNAL OF CLINICAL INVESTIGATION
- Tie1 controls angiopoietin function in vascular remodeling and inflammation
- (2016) Emilia A. Korhonen et al. JOURNAL OF CLINICAL INVESTIGATION
- Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial
- (2016) William D Tap et al. LANCET
- Ibrutinib Inhibits ERBB Receptor Tyrosine Kinases and HER2-Amplified Breast Cancer Cell Growth
- (2016) Jun Chen et al. MOLECULAR CANCER THERAPEUTICS
- A Randomized Phase II Study of FOLFOX With or Without the MET Inhibitor Onartuzumab in Advanced Adenocarcinoma of the Stomach and Gastroesophageal Junction
- (2016) M. A. Shah et al. ONCOLOGIST
- Soluble IL-33 receptor sST2 inhibits colorectal cancer malignant growth by modifying the tumour microenvironment
- (2016) Miho Akimoto et al. Nature Communications
- CCL24 contributes to HCC malignancy via RhoB- VEGFA-VEGFR2 angiogenesis pathway and indicates poor prognosis
- (2016) Lei Jin et al. Oncotarget
- The role of IL-21 in immunity and cancer
- (2015) Matthew R. Davis et al. CANCER LETTERS
- CCL5 promotes vascular endothelial growth factor expression and induces angiogenesis by down-regulating miR-199a in human chondrosarcoma cells
- (2015) Guan-Ting Liu et al. CANCER LETTERS
- Anti-angiogenic alternatives to VEGF blockade
- (2015) Kabir A. Khan et al. CLINICAL & EXPERIMENTAL METASTASIS
- A Phase I First-in-Human Study of Nesvacumab (REGN910), a Fully Human Anti-Angiopoietin-2 (Ang2) Monoclonal Antibody, in Patients with Advanced Solid Tumors
- (2015) K. P. Papadopoulos et al. CLINICAL CANCER RESEARCH
- Tryptase, a novel angiogenic factor stored in mast cell granules
- (2015) Domenico Ribatti et al. EXPERIMENTAL CELL RESEARCH
- Genomic Instability Causes HGF Gene Activation in Colon Cancer Cells, Promoting Their Resistance to Necroptosis
- (2015) Danushka Seneviratne et al. GASTROENTEROLOGY
- Glucocorticoid-induced tumor necrosis factor receptor–related protein co-stimulation facilitates tumor regression by inducing IL-9–producing helper T cells
- (2015) Il-Kyu Kim et al. NATURE MEDICINE
- Combination of IL-24 and cisplatin inhibits angiogenesis and lymphangiogenesis of cervical cancer xenografts in a nude mouse model by inhibiting VEGF, VEGF-C and PDGF-B
- (2015) ZHAOXIA WANG et al. ONCOLOGY REPORTS
- Interleukin-21 sustains inflammatory signals that contribute to sporadic colon tumorigenesis
- (2015) Veronica De Simone et al. Oncotarget
- CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer
- (2015) Ling Lin et al. Oncotarget
- The IL-33/ST2 pathway contributes to intestinal tumorigenesis in humans and mice
- (2015) Kirsten D. Mertz et al. OncoImmunology
- Modulating Antiangiogenic Resistance by Inhibiting the Signal Transducer and Activator of Transcription 3 Pathway in Glioblastoma
- (2015) John de Groot et al. Oncotarget
- IL-33/ST2 pathway contributes to metastasis of human colorectal cancer
- (2014) Xuejian Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Dynamics of the IL-33/ST2 network in the progression of human colorectal adenoma to sporadic colorectal cancer
- (2014) Guanglin Cui et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Melanoma-derived IL-1 converts vascular endothelium to a proinflammatory and procoagulatory phenotype via NFκB activation
- (2014) Elwira A. Strozyk et al. EXPERIMENTAL DERMATOLOGY
- IFNγ-responsiveness of endothelial cells leads to efficient angiostasis in tumours involving down-regulation of Dll4
- (2014) Jingjing Deng et al. JOURNAL OF PATHOLOGY
- Interleukin-33 induces urokinase in human endothelial cells―possible impact on angiogenesis
- (2014) S. Stojkovic et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- FDA Approval Summary: Crizotinib for the Treatment of Metastatic Non-Small Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangements
- (2014) D. Kazandjian et al. ONCOLOGIST
- The Role of Angiopoietins as Potential Therapeutic Targets in Renal Cell Carcinoma
- (2014) Xiaoen Wang et al. Translational Oncology
- IL-17 family: Cytokines, receptors and signaling
- (2013) Chunfang Gu et al. CYTOKINE
- N-myc Downstream-regulated Gene 1 Promotes Tumor Inflammatory Angiogenesis through JNK Activation and Autocrine Loop of Interleukin-1α by Human Gastric Cancer Cells
- (2013) Yuichi Murakami et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer
- (2013) Puja Kachroo et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Tumor-Derived IL-35 Promotes Tumor Growth by Enhancing Myeloid Cell Accumulation and Angiogenesis
- (2013) Z. Wang et al. JOURNAL OF IMMUNOLOGY
- Targeting Receptor Tyrosine Kinase MET in Cancer: Small Molecule Inhibitors and Clinical Progress
- (2013) J. Jean Cui JOURNAL OF MEDICINAL CHEMISTRY
- An interleukin-17–mediated paracrine network promotes tumor resistance to anti-angiogenic therapy
- (2013) Alicia S Chung et al. NATURE MEDICINE
- Inhibition of IL-17A in Tumor Microenvironment Augments Cytotoxicity of Tumor-Infiltrating Lymphocytes in Tumor-Bearing Mice
- (2013) Keiji Hayata et al. PLoS One
- Angiopoietin-2 Is Critical for Cytokine-Induced Vascular Leakage
- (2013) Andrew V. Benest et al. PLoS One
- Vascular endothelial growth factor-dependent spatiotemporal dual roles of placental growth factor in modulation of angiogenesis and tumor growth
- (2013) Xiaojuan Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanism of pro-tumorigenic effect of BMP-6: Neovascularization involving tumor-associated macrophages and IL-1α
- (2013) Seok Joo Kwon et al. PROSTATE
- Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasis
- (2012) Y S Lee et al. BRITISH JOURNAL OF CANCER
- Constitutive Type I Interferon Modulates Homeostatic Balance through Tonic Signaling
- (2012) Daniel J. Gough et al. IMMUNITY
- G-CSF rescues tumor growth and neo-angiogenesis during liver metastasis under host angiopoietin-2 deficiency
- (2012) Jae Hong Im et al. INTERNATIONAL JOURNAL OF CANCER
- A Novel Monoclonal Antibody to Fibroblast Growth Factor 2 Effectively Inhibits Growth of Hepatocellular Carcinoma Xenografts
- (2012) L. Wang et al. MOLECULAR CANCER THERAPEUTICS
- Stromal Platelet-Derived Growth Factor Receptor (PDGFR ) Provides a Therapeutic Target Independent of Tumor Cell PDGFR Expression in Lung Cancer Xenografts
- (2012) D. E. Gerber et al. MOLECULAR CANCER THERAPEUTICS
- Changes in Circulating Pro-Angiogenic Cytokines, other than VEGF, before Progression to Sunitinib Therapy in Advanced Renal Cell Carcinoma Patients
- (2012) Camillo Porta et al. ONCOLOGY
- A Protective Role by Interleukin-17F in Colon Tumorigenesis
- (2012) Zan Tong et al. PLoS One
- Glioblastoma Cell-Secreted Interleukin-8 Induces Brain Endothelial Cell Permeability via CXCR2
- (2012) Julie Dwyer et al. PLoS One
- An IP-10 (CXCL10)-Derived Peptide Inhibits Angiogenesis
- (2012) Cecelia C. Yates-Binder et al. PLoS One
- IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma
- (2011) Jiankun Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Lactate Influx through the Endothelial Cell Monocarboxylate Transporter MCT1 Supports an NF- B/IL-8 Pathway that Drives Tumor Angiogenesis
- (2011) F. Vegran et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Classification of Diet-Modulated Gene Signatures at the Colon Cancer Initiation and Progression Stages
- (2011) Priyanka Kachroo et al. DIGESTIVE DISEASES AND SCIENCES
- IL-20 is epigenetically regulated in NSCLC and down regulates the expression of VEGF
- (2011) Anne-Marie Baird et al. EUROPEAN JOURNAL OF CANCER
- FGF-dependent regulation of VEGF receptor 2 expression in mice
- (2011) Masahiro Murakami et al. JOURNAL OF CLINICAL INVESTIGATION
- c-MET as a potential therapeutic target and biomarker in cancer
- (2011) J. Rafael Sierra et al. Therapeutic Advances in Medical Oncology
- Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapy
- (2010) V Goede et al. BRITISH JOURNAL OF CANCER
- Tumor-infiltrating IL-17-producing γδ T cells support the progression of tumor by promoting angiogenesis
- (2010) Daiko Wakita et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Neutrophils responsive to endogenous IFN-β regulate tumor angiogenesis and growth in a mouse tumor model
- (2010) Jadwiga Jablonska et al. JOURNAL OF CLINICAL INVESTIGATION
- Chemokine CXCL14/BRAK transgenic mice suppress growth of carcinoma cell xenografts
- (2010) Kazuhito Izukuri et al. TRANSGENIC RESEARCH
- Pericellular activation of hepatocyte growth factor by the transmembrane serine proteases matriptase and hepsin, but not by the membrane-associated protease uPA
- (2009) Kate A. Owen et al. BIOCHEMICAL JOURNAL
- Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production
- (2009) Y.-S. Choi et al. BLOOD
- Angiopoietin-2 Levels Are Associated with Disease Progression in Metastatic Malignant Melanoma
- (2009) I. Helfrich et al. CLINICAL CANCER RESEARCH
- Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients
- (2009) Yuji Toiyama et al. INTERNATIONAL JOURNAL OF CANCER
- Somatic mutation and functional polymorphism of a novel regulatory element in the HGF gene promoter causes its aberrant expression in human breast cancer
- (2009) Jihong Ma et al. JOURNAL OF CLINICAL INVESTIGATION
- Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study
- (2009) Christopher G. Willett et al. JOURNAL OF CLINICAL ONCOLOGY
- Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients
- (2009) Jing-Ping Zhang et al. JOURNAL OF HEPATOLOGY
- IL-1α secreted by colon cancer cells enhances angiogenesis: The relationship between IL-1α release and tumor cells' potential for liver metastasis
- (2009) Yoichi Matsuo et al. JOURNAL OF SURGICAL ONCOLOGY
- IL-12 Can Target Human Lung Adenocarcinoma Cells and Normal Bronchial Epithelial Cells Surrounding Tumor Lesions
- (2009) Irma Airoldi et al. PLoS One
- Nuclear Interleukin-33 Is Generally Expressed in Resting Endothelium but Rapidly Lost upon Angiogenic or Proinflammatory Activation
- (2008) Axel M. Küchler et al. AMERICAN JOURNAL OF PATHOLOGY
- Interleukin-1α Secreted by Pancreatic Cancer Cells Promotes Angiogenesis and Its Therapeutic Implications
- (2008) Yoichi Matsuo et al. JOURNAL OF SURGICAL RESEARCH
- Interleukin-1α Enhances Angiogenesis and Is Associated With Liver Metastatic Potential in Human Gastric Cancer Cell Lines
- (2007) Jiachi Ma et al. JOURNAL OF SURGICAL RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now